← back to search

Anil Korkut

The University of Texas MD Anderson Cancer Center · US
🔎 Find collaborators in Cancer Research · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, and Colorectal Cancer Treatments and Studies.
h-index
46
citations
45,307
works
237
NIH funding
primary concept
Biology
email

Recent publications

The immunogenomic landscape of resected intrahepatic cholangiocarcinoma
Hepatology 2021cited by 71position: middledoi
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines
Cancer Cell 2020cited by 67position: middledoi
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Cell Reports 2019cited by 766position: middledoi
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Cell 2018cited by 3,906position: middledoi
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Cell 2018cited by 2,670position: middledoi
Comprehensive Characterization of Cancer Driver Genes and Mutations
Cell 2018cited by 2,493position: middledoi
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Cell 2018cited by 2,331position: middledoi
The chromatin accessibility landscape of primary human cancers
Science 2018cited by 1,316position: middledoi
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Cell Reports 2018cited by 1,220position: middledoi
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Cancer Cell 2018cited by 1,182position: middledoi
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Cell Reports 2018cited by 1,045position: middledoi
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Cancer Cell 2018cited by 954position: middledoi
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Cell Systems 2018cited by 936position: middledoi
Pathogenic Germline Variants in 10,389 Adult Cancers
Cell 2018cited by 879position: middledoi
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Cell Reports 2018cited by 800position: middledoi
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Cancer Cell 2018cited by 709position: middledoi
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Cancer Cell 2018cited by 697position: middledoi
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Cell Reports 2018cited by 511position: middledoi
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Cancer Cell 2018cited by 485position: middledoi
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Cell Systems 2018cited by 441position: middledoi
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Cell 2018cited by 434position: middledoi
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Cell Reports 2018cited by 390position: middledoi
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Cell Reports 2018cited by 276position: middledoi
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Cell Reports 2018cited by 248position: middledoi
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Cell Reports 2018cited by 186position: middledoi
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
Cell Reports 2018cited by 124position: middledoi
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Clinical Cancer Research 2018cited by 97position: middledoi
Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells
eLife 2015cited by 119position: firstdoi
Protein Domain Hotspots Reveal Functional Mutations across Genes in Cancer
bioRxiv (Cold Spring Harbor Laboratory) 2015cited by 1position: middledoi
Perturbation Biology: Inferring Signaling Networks in Cellular Systems
PLoS Computational Biology 2013cited by 195position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chris Sander · Athinoula A. Martinos Center for Biomedical Imaging3 papers (2013–2015)Bülent Arman Aksoy · Barricaid (United States)2 papers (2015–2015)André Schultz · Stanford University2 papers (2019–2020)Rehan Akbani · The University of Texas MD Anderson Cancer Center2 papers (2019–2020)Evan Molinelli · Memorial Sloan Kettering Cancer Center2 papers (2013–2015)Martin L. Miller · AstraZeneca (United Kingdom)2 papers (2013–2015)Christine A. Pratilas · Johns Hopkins University2 papers (2013–2015)Nicholas P. Gauthier · National Laboratory of the Rockies2 papers (2013–2015)Weiqing Wang · The First Affiliated Hospital, Sun Yat-sen University2 papers (2013–2015) · 2 papers (2013–2015)David B. Solit · New York Oncology Hematology2 papers (2013–2015)Gordon B. Mills · Massachusetts General Hospital2 papers (2013–2020)Özgün Babur · University of Massachusetts Boston2 papers (2015–2019)Dennis J. Slamon · APLA Health1 papers (2020–2020)Maria Cardenas · Universidad Santo Tomás1 papers (2019–2019)Yikai Luo · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)Yancey Lawrence · Oregon Health & Science University1 papers (2020–2020)Yiling Lu · Nantong University1 papers (2020–2020) · 1 papers (2015–2015)Olivier Lichtarge · Baylor College of Medicine1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Oncology →